Galit Levin
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Cell death mechanisms and regulation 5
-
- Advancements in Transdermal Drug Delivery 7
- Co-authors
- Shoshana Mokady (6 shared papers)Avi Cohen (10 shared papers)Hagit Grimberg (10 shared papers)Anat Shirvan (10 shared papers)Ilan Ziv (10 shared papers)Ayelet Reshef (10 shared papers)Amiram Raz (3 shared papers)Uri Cogan (2 shared papers)
- Journals
- Advanced Healthcare Materials (2 papers)APOPTOSIS (2 papers)Journal of Controlled Release (2 papers)Clinical Cancer Research (1 paper)Journal of Biomedical Optics (1 paper)
- Partner nations
- IsraelUnited KingdomUnited States
In The Last Decade
Galit Levin
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 106
- Pharmaceutical Science 382
- Biochemistry 156
- Dermatology 199
- Biotechnology 64
- Molecular Biology 478
Countries citing papers authored by Galit Levin
This map shows the geographic impact of Galit Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galit Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galit Levin more than expected).
Fields of papers citing papers by Galit Levin
This network shows the impact of papers produced by Galit Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galit Levin. The network helps show where Galit Levin may publish in the future.
Co-authors
The 25 scholars most cited alongside Galit Levin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 125 | |
| 2 | 2005 | 101 | |
| 3 | 1994 | 92 | |
| 4 | 2003 | 89 | |
| 5 | 2009 | 89 | |
| 6 | 2006 | 84 | |
| 7 | 2002 | 71 | |
| 8 | 2005 | 70 | |
| 9 | 2020 | 69 | |
| 10 | 2008 | 61 | |
| 11 | 1990 | 60 | |
| 12 | 1997 | 57 | |
| 13 | 2001 | 56 | |
| 14 | 2006 | 44 | |
| 15 | 2009 | 42 | |
| 16 | 2007 | 30 | |
| 17 | 1992 | 29 | |
| 18 | 2007 | 28 | |
| 19 | 2014 | 28 | |
| 20 | 2008 | 25 |
About Galit Levin
Galit Levin is a scholar working on Molecular Biology, Pharmaceutical Science, Biochemistry, Biomedical Engineering and Surgery, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (7 papers), Cell death mechanisms and regulation (5 papers), Antioxidant Activity and Oxidative Stress (4 papers), Molecular Sensors and Ion Detection (3 papers), Inflammatory mediators and NSAID effects (3 papers), Metal complexes synthesis and properties (3 papers), Nanoplatforms for cancer theranostics (2 papers) and Bee Products Chemical Analysis (2 papers). The work is most often cited by research in Pharmaceutical Science (382 citations), Biochemistry (156 citations), Dermatology (199 citations), Biotechnology (64 citations) and Molecular Biology (478 citations). Galit Levin has collaborated with scholars based in Israel, United Kingdom and United States. Frequent co-authors include Shoshana Mokady, Avi Cohen, Hagit Grimberg, Anat Shirvan, Ilan Ziv, Ayelet Reshef, Amiram Raz, Uri Cogan, Dvora Kidron and Helen O. McCarthy. Their work appears in journals such as Advanced Healthcare Materials, APOPTOSIS, Journal of Controlled Release, Clinical Cancer Research and Journal of Biomedical Optics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.